LMRI Company Profile and Key Details

Short-term trend indicators are bullishly aligned (SMA20 7.59%, SMA50 -5.83%, SMA200 -6.58%). The stock’s 14-day RSI is 50.2 (neutral), while the ATR of 1.23 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -25.81% below its high and over 44.81% above its low. Average 10-day trading volume of 498.99 thousand shares is below the 3-month average of 868.39 thousand, indicating normal recent market interest.

Analyst sentiment is bullish. Analyst rating data shows there are 4 Strong Buy ratings, 2 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $23.00 to $15.00. The high target offers 123.74% upside. The low target suggests 45.91% downside. The mean target is $21.50. This offers 109.14% upside. Lumexa Imaging Holdings, Inc. Common Stock earnings surprise history is a mixed track record. The quarter that ended March 26, 2026, missed forecasts by -1420.0%.

Lumexa Imaging Holdings, Inc. Common Stock last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$11.19. This means the shares are trading below this model’s fair value.

Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ:LMRI) closed at $10.28 USD, gaining $0.55 (5.65%) from the previous close of $9.73. The stock is currently mid-range between its 52-week high and low $7.23 and $19.45. With a market capitalization of about $988.01 million, Lumexa Imaging Holdings, Inc. Common Stock is classified as a small-cap and shows higher-than-market volatility (beta ~2.53). Key stats such as the average daily volume over the past year has been around 888.07 thousand shares, volume is running light vs its 52-week average. Headquartered in Raleigh, NC, Lumexa Imaging Holdings, Inc. Common Stock operates in the Healthcare sector and the Medical - Devices industry. Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States.

Our AI price prediction model suggests that Lumexa Imaging Holdings, Inc. Common Stock stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

currently trading near 52-week highs band. Valuation shows Lumexa Imaging Holdings, Inc. Common Stock trading at a premium to the broader market with a P/E of -14.35. Analyst sentiment is bullish, with the majority of ratings in Overweight territory and a mean price target of $21.50, suggesting 109.14% upside.

Lumexa Imaging Holdings, Inc. Common Stock trades at a P/E ratio of -14.35, slightly below the S&P 500 average, with a price-to-sales ratio of 1.91 and a price-to-book ratio of 1.32 suggesting the stock is closer to book value. The P/FCF stands at 30.48, also below market averages.